From the CMS doc “Medicare Drug Worth Negotiation Program: Chosen Medication for Preliminary Worth
Applicability 12 months 2027“:
On January 17, 2025, CMS introduced the collection of the under checklist of 15 medicine coated below Medicare Half D for the second cycle of negotiations (preliminary worth applicability yr 2027), based mostly on whole gross coated prescription drug prices below Medicare Half D and different standards as required by the legislation.
With the Trump inauguration to happen on Monday, will the Medicare Drug Worth Negotiation course of change with the brand new administration? Anna Kaltenboeck notes in EndPoints Information:
…the following administration is not going to have “blanket authority to alter the core elements of the legislation,” sure features of the method could be modified with out legislative motion.
For instance, CMS might alter its steerage or the way it interprets elements of the legislation, comparable to what number of occasions it meets with drugmakers, or what number of listening periods it holds. “The diploma to which they play hardball with producers within the course of might change,” she stated.
